FindTrial
Sign In

Platelet-rich plasma for total hip replacement in the geriatric patient with hip fracture

Platelet-rich plasma for total hip replacement in the geriatric patient with hip fracture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034598
Enrollment
Unknown
Registered
2020-07-11
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

Control group:The wound was treated with normal saline
Treatment group:The wound was treated with platelet-rich plasma

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Aged > 65 years , weight> 50kg, all gender; 2. Hip fracture, no history of hip operation; 4. ASA grade I-II;

Exclusion criteria

Exclusion criteria: 1. Severe dysfunction of lung, heart, kidney and liver, or abnormal coagulation function; 2. Fractures in other parts, surgery is required at the same time; 3. Preoperative fever or anemia; 4. spinal anesthesia or total hip replacement can not be performed.

Design outcomes

Primary

MeasureTime frame
VAS score;Postoperative drainage;Postoperative blood transfusion;blood routine examination;—

Secondary

MeasureTime frame
Adverse reaction;Infection;Functional recovery;—

Countries

China

Contacts

Public ContactWang Geng

Beijing Jishuitan Hospital

w_geng@163.com+86 13910676672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026